09-11, 15:00–15:30 (Europe/Istanbul), Head & Neck 2 (Hilton - Connie 3)
Transoral margin clearing operations and neck dissection(s) are the best way to begin the cancer care of the oropharyngeal cancer patient. Twenty to 25% of patients can then avoid radiation/chemoradiation. The rest can receive a lower dose of standard adjuvant radiation OR a majority can be de-escalated with demonstrated reduced morbidity without compromising survival. This presentation will share Mayo Clinic’s experience to date with de-escalation of adjuvant radiation or DART.
The purpose is to inspire others to consider the Mayo Clinic approach to de-escalation for patients with Early-Stage HPV Positive Oropharyngeal Cancer.
Gerald F. Hamra Professor in Otolaryngology-Head & Neck Surgery
Diplomate , American Board of Otolaryngology
Diplomate, American Board of Facial Plastic and Reconstructive Surgery
Director, Head and Neck Fellowship Program
Department of Otolaryngology-Head & Neck Surgery
University of Arkansas for Medical Sciences
- Patient’s Needs Vs Surgeon’s Desires Choosing The Optimal Reconstruction For The Defect
- Orbital And Optic Nerve Decompression: When And How?
- Management Of Early-Stage Oropharyngeal Cancers
- Reconstruction Of The Defects Of The Nose: Strategies From Simple To Complex
- Surgery Or Radiotherapy For HPV Positive Oropharyngeal Cancer
